⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9587591 | 0.86 | MEN1 (0.48) | — | |
| SCHEMBL18850698 | 0.86 | MEN1 (0.48) | — | |
| SCHEMBL12355650 | 0.85 | TSHR (0.63) | — | |
| SCHEMBL9340071 | 0.84 | EPHX1 (0.52) | — | |
| SCHEMBL26355362 | 0.83 | EPHX1 (0.63) | — | |
| SCHEMBL26928170 | 0.83 | — | — | |
| SCHEMBL3190326 | 0.83 | EPHX1 (0.61) | — | |
| SCHEMBL9493217 | 0.81 | ACHE (0.50) | — | |
| Ammonia Solution, Strong SCHEMBL9998424 | 0.81 | ACHE (0.55) | — | |
| SCHEMBL6468831 | 0.81 | GAA (0.55) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105409050-B | Non-aqueous electrolyte for lithium secondary battery and lithium secondary battery comprising same | 株式会社LG化学 | 2017-09-29 | — | — | CN | claimed |
| CN-105409050-A | Non-aqueous electrolyte for lithium secondary battery and lithium secondary battery comprising same | LG CHEMICAL LTD | 2016-03-16 | — | — | CN | claimed |
| WO-2023230609-A1 | HETEROCYCLIC PAD4 INHIBITORS | CELGENE CORPORATION (US) | 2023-11-30 | — | — | WO | disclosed |
| CN-102210054-B | Electrolyte having eutectic mixture and nitrile compound and electrochemical device containing the same | 株式会社LG化学 | 2018-09-07 | — | — | CN | disclosed |
| US-9804296-B2 | Hydrophilic macromers and hydrogels comprising the same | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2017-10-31 | — | — | US | disclosed |
| US-9804296-B2 | Hydrophilic macromers and hydrogels comprising the same | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2017-10-31 | — | — | US | disclosed |
| US-9765087-B2 | Benzimidazole derivatives | ENANTA PHARMACEUTICALS, INC. (US) | 2017-09-19 | — | — | US | disclosed |
| US-20170114046-A1 | NOVEL BENZIMIDAZOLE DERIVATIVES | ENANTA PHARM INC (US) | 2017-04-27 | — | — | US | disclosed |
| US-9440958-B2 | Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases | INCYTE CORPORATION (US) | 2016-09-13 | — | — | US | disclosed |
| CN-105409050-A | Non-aqueous electrolyte for lithium secondary battery and lithium secondary battery comprising same | LG CHEMICAL LTD | 2016-03-16 | — | — | CN | disclosed |
| US-20150025056-A1 | SUBSTITUTED CYCLIC HYDROXAMATES AS INHIBITORS OF MATRIX METALLOPROTEINASES | INCYTE CORPORATION (US) | 2015-01-22 | — | — | US | disclosed |
| EP-2119702-A1 | AMIDE DERIVATIVE | Dainippon Sumitomo Pharma Co., Ltd. (JP) | 2009-11-18 | — | — | EP | disclosed |
| US-20090281292-A1 | 10a-Azalide Compound | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2009-11-12 | — | — | US | disclosed |
| US-20090281292-A1 | 10a-Azalide Compound | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2009-11-12 | — | — | US | disclosed |
| US-20090215979-A1 | Process for the preparation of alkoxyamine functionalized polyethylene glycols | NOVO NORDISK A/S (DK) | 2009-08-27 | — | — | US | disclosed |
| WO-2008036216-A1 | PIPERIDINE DERIVATIVES AS RENIN INHIBITORS | VITAE PHARMACEUTICALS, INC. (US) | 2008-03-27 | — | — | WO | disclosed |
| WO-2007117560-A2 | PIPERIDINE AND MORPHOLINE RENIN INHIBITORS | VITAE PHARMACEUTICALS, INC. (US) | 2007-10-18 | — | — | WO | disclosed |
| WO-2007070201-A1 | ASPARTIC PROTEASE INHIBITORS | VITAE PHARMACEUTICALS, INC. (US) | 2007-06-21 | — | — | WO | disclosed |
| US-20070049593-A1 | Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor | JAPAN TOBACCO INC. (JP) | 2007-03-01 | — | — | US | disclosed |
| US-20070049593-A1 | Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor | JAPAN TOBACCO INC. (JP) | 2007-03-01 | — | — | US | disclosed |